<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Dural venous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> is a rare and potentially devastating disease </plain></SENT>
<SENT sid="1" pm="."><plain>Several predisposing factors exist, including oral contraceptive therapy and <z:hpo ids='HP_0002583'>colitis</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>First-line therapy consists of systemic anticoagulation </plain></SENT>
<SENT sid="3" pm="."><plain>If first-line therapies fail, more aggressive endovascular therapies may be performed </plain></SENT>
<SENT sid="4" pm="."><plain>We report our initial experience with the Solitaire FR device for treatment of refractory symptomatic dural venous sinus <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
</text></document>